Pharma

Your Article Summary

See Latest Articles

Cytokinetics to Present Phase IIa Clinical Trials Data on Omecamtiv Mecarbil at the 2009 Heart Failure Society of America Annual Meeting
Cytokinetics, 09/09/09

Cytokinetics, Incorporated announced that data relating to two Phase IIa clinical trials evaluating omecamtiv mecarbil, one in stable heart failure patients and one in patients with ischemic cardiomyopathy and angina, are scheduled to be presented in three poster presentations at the 2009 Heart Failure Society of America Annual Meeting, to be held September 2009 in Boston, Massachusetts.

Today in Conferences/Meetings...keeping you current

Receive free subspecialty "5-minute updates" via email

Quality of trials reported as conference abstracts in China: How well are they reported
International Journal of Technology Assessment in Health Care, 11/05/09

User Groups Prove Helpful
HealthDataManagement, 11/03/09

Salix Pharmaceuticals Reviews American Association For The Study Of Liver Diseases Annual Meeting
Salix Pharmaceuticals, 11/03/09

See All of Conferences/Meetings

Today in Drug Trials...keeping you current

Receive free subspecialty "5-minute updates" via email

A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
New England Journal of Medicine, 11/20/09

Intravenous Drug Administration During Out-of-Hospital Cardiac Arrest: A Randomized Trial
JAMA, 11/25/09

Abbott to Acquire Novel Investigational Biologic to Treat Chronic Pain
Abbott, 11/16/09

See All of Drug Trials